 |
|
|
| |
Substantial rates of Acute Hepatitis C Reinfection in European HIV-positive Patients
|
| |
| |
Reported by Jules Levin 14th European AIDS Conference 16-19 October, 2013 Brussels, Belgium
ID Week: Acute HCV Treatment/HIV+ MSM/HCV Screening/New HCV Therapies: "Determinants of Response to Pegylated Interferon and Ribavirin for Acute Hepatitis C Infection in Patients with Human Immunodeficiency Virus" - (10/16/13)
HCV Reinfection - (10/11/13)
High incidence of hepatitis C virus reinfection within a cohort of injecting drug users - (10/13/13)
Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine - (10/10/13)
High incidence of hepatitis C virus reinfection within a cohort of injecting drug users - (10/10/13)
Hepatitis C virus reinfection in injection drug users - (10/10/13)
pontaneous Control of Primary Hepatitis C Virus Infection and Immunity Against Persistent Reinfection - (10/10/13)
P.Ingiliz, T.C.Martin, C.Boesecke, S.Mauss, B.A.Payer, M.Mandorfer, A.Baumgarten, H.-J.Stellbrink, S.Bhagani, J.K.Rockstroh, M.Nelson, and the NEAT Study Group
HIV-infected patients may be different due to a number of factors including high HCV viral loads, the proportion of genotype 1, 4 infection and possible adverse impact of HIV-associated immune suppression.
|
| |
|
|
|
|
|
